Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort

Overview of attention for article published in Movement Disorders, March 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#13 of 6,301)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 52 news outlets
twitter: 3 X users
patent: 2 patents

facebook: 1 Facebook page
guideline: 1 clinical guideline source

Readers on

mendeley: 257 Mendeley

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 13,931 followers.

Clinical trials in patients with early stage Parkinson’s may benefit from assessing markers of disease progression. Find out more here: https://t.co/PrLZ4faakU

RT @ScienceofPD: The #Parkinsons Progression Marker Initiative presents 5‐year longitudinal data on the change of the MDS‐UPDRS & other cli…

The #Parkinsons Progression Marker Initiative presents 5‐year longitudinal data on the change of the MDS‐UPDRS & other clinical measures as well as dopamine transporter imaging outcomes in early PD https://t.co/iud1txqNBv https://t.co/ELXKXOpzIE

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.